New Nipah virus vaccine safe, generates immune response: The Lancet

Nipah virus vaccine found safe, shows immune response: The Lancet

New Delhi: A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.  All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet. "The induction of antibodies within 1 month of vaccination, along with the persistence afforded…

The Lancet study shows new Nipah virus vaccine safe, generates immune response

The World Health Organization has listed the Nipah virus as a high-priority pathogen because it kills up to 82 per cent of people who are infected, and there are no approved treatments or vaccines to prevent it.

New Nipah virus vaccine safe, generates immune response: The Lancet

New Delhi, Dec 23 (SocialNews.XYZ) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection. All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet. "The induction of antibodies within 1 month of vaccination, along with t…